WuXi AppTec, CNE100003F19

WuXi AppTec raised 2026 guidance while WuXi AppTec stock stood at EUR 23.63

Published on 10/13/2026 at 09:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue reached RMB 28.90 billion, up 38.93 percent year over year. WuXi AppTec stock costs EUR 23.63 on October 13, 2026.

Key points in brief

  • WuXi AppTec raised its 2026 revenue guidance after strong first-half growth.
  • First-half revenue reached RMB 28.90 billion, up 38.93 percent year over year.
  • WuXi AppTec stock was trading at EUR 23.63 at Lang & Schwarz on October 13, 2026 at 9:19 a.m. CEST.
  • Quarterly results are scheduled for October 27, 2026.
WuXi AppTec, CNE100003F19, Illustration mit AI erstellt.
WuXi AppTec, CNE100003F19, Illustration mit AI erstellt.

WuXi AppTec (CNE100003F19) was trading at EUR 23.63 at Lang & Schwarz on October 13, 2026 at 9:19 a.m. CEST after the company had raised its 2026 revenue guidance. According to GMT Eight on October 9, 2026, Huaxi Securities reported that first-half revenue reached RMB 28.897 billion, up 38.93 percent year over year, while the guidance range increased to RMB 58.5-60.5 billion.

Guidance reset raises the bar

Huaxi Securities said WuXi AppTec lifted its 2026 revenue range from RMB 51.3-53.0 billion to RMB 58.5-60.5 billion. The continuing-operations growth outlook rose from 18-22 percent to 35-39 percent, while the adjusted net profit margin guidance stayed relatively stable.

The first-half order picture also supplied a measurable operating counterweight to valuation concerns. Sustained-business backlog stood at RMB 59.77 billion at June 30, 2026, up 23.6 percent year over year, according to GMT Eight.

What does guidance mean for growth?

The raised outlook shifts attention from recovery to delivery. Small-molecule development and manufacturing revenue reached RMB 14.99 billion in the first half of 2026, up 72.7 percent year over year, according to Peptide and Protein.

Three dated operating signals

On August 3, 2026, WuXi AppTec reported first-half revenue of RMB 28.90 billion and raised 2026 capital expenditure guidance to RMB 7.5-8.5 billion, according to Peptide and Protein. On September 23, 2026, all RMB 6.78 billion of the companys 2027 convertible bonds had converted into H shares, the same report said. On October 7, 2026, WuXi AppTec received its third consecutive EcoVadis Gold medal, as the company states on its investor-relations page.

Next results date

WuXi AppTec is expected to publish results for the quarter ended September 30, 2026, on October 27, 2026, with consensus estimates of HKD 2.97 earnings per share and HKD 18.10 billion revenue, according to Finanzen.

Stock price and listing

WuXi AppTec was trading at EUR 23.63 at Lang & Schwarz on October 13, 2026 at 9:19 a.m. CEST. The Hong Kong-listed H shares trade under ticker 2359, and the listing is identified with ISIN CNE100003F19 by El Fondo. The further course of trading is shown by the continuously updated real-time quote of WuXi AppTec stock.

WuXi AppTec stock facts

  • Company: WuXi AppTec Co., Ltd.
  • ISIN: CNE100003F19
  • Ticker: 2359
  • Primary exchange: HKEX
  • Price Lang & Schwarz as of October 13, 2026, 9:19 a.m. CEST: EUR 23.63

Market context: Latest market reports.

More news and analyses on WuXi AppTec stock

Disclaimer...

en | CNE100003F19 | WUXI APPTEC | boerse | 70311119 | bgmi